CPRX Operating Income Growth
Catalyst Pharmaceuticals Inc · Operating Income Growth
CPRX Operating Income Growth
Year-over-year change vs the same period a year earlier
Latest reported15.68%period ending
CPRX TTM Operating Income YoY % (-434.47% → 15.68%)
Year-over-year change
High-resolution chart · PNG
CPRX operating income growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Income Growth |
|---|---|
| 15.68% | |
| 32.1098% | |
| 48.7443% | |
| 183.4517% | |
| 195.3759% | |
| 124.7662% | |
| 129.15% | |
| -37.866% | |
| -34.7699% | |
| -14.7548% | |
| -9.3794% | |
| 90.1611% | |
| 100.3019% | |
| 94.403% | |
| 73.5962% | |
| 58.1368% | |
| 48.3737% | |
| 26.8288% | |
| 18.5986% | |
| 7.3006% | |
| -7.1391% | |
| 29.791% | |
| 353.4848% | |
| 428.1159% | |
| 243.3666% | |
| 190.1632% | |
| 134.561% | |
| 40.8974% | |
| -52.256% | |
| -88.95% | |
| -48.5163% | |
| -29.2488% | |
| -12.4738% | |
| 3.1149% | |
| 17.3726% | |
| 23.2322% | |
| 20.6831% | |
| 5.4816% | |
| -16.3115% | |
| -28.8099% | |
| -45.3269% | |
| -39.7968% | |
| -36.6221% | |
| -38.7985% | |
| -26.9129% | |
| -41.5042% | |
| -46.1511% | |
| -74.1913% | |
| -117.8155% | |
| -97.4982% | |
| -58.4307% | |
| -27.7003% | |
| 6.1701% | |
| 14.1562% | |
| -20.2998% | |
| -22.8236% | |
| -31.9291% | |
| -51.1398% | |
| -7.1309% | |
| 5.9484% | |
| 14.9253% | |
| 44.6878% | |
| 54.9189% | |
| 57.9362% | |
| 56.7622% | |
| 33.2162% | |
| -20.0371% | |
| -83.4124% | |
| -132.4785% | |
| -116.7031% | |
| -72.8628% | |
| -21.6836% | |
| -29.3457% | |
| -73.4532% | |
| -43.0291% | |
| -130.9999% | |
| -58.8097% | |
| -0.4528% | |
| -96.3391% | |
| -40.3898% | |
| -140.0087% | |
| -434.4741% |